2022年6月1日 · Long Acting Injectables (LAIs) are a drug formulation option that provide a slow and sustained release of the Active Pharmaceutical Ingredient (API) after administration. 1 LAI …

2021年12月2日 · Suspensions of crystalline drug particles, in the nanometer to micron size range, are often used for sustained-release injectable formulation, especially in the case of poorly …

• Injectable suspensions are suspension products for parenteral routes of administration: intramuscular (IM), subcutaneous, intra -articular, intravenous (IV), intra-ocular, etc.

2023年4月28日 · Long-acting injectables (LAIs) are pharmaceutical products intended for weekly, monthly, or with an even lower administration frequency, which provides a continued drug …

Drug crystal suspensions, liposomes, and polymeric microparticles are the most commonly LAI dosage forms. Implants, oils suspensions, and in situ polymeric gels are also available in the …

UZEDY (risperidone) extended-release injectable suspension for subcutaneous use is indicated for the treatment of schizophrenia in adults. WARNING: INCREASED MORTALITY IN …

2024年7月18日 · Most parenteral suspensions are designed for intramuscular or subcutaneous administration. For example, Triamcinolone Acetonide Injectable suspension and insulin zinc …

2023年12月15日 · Our present work elucidated the operational feasibility of direct generation and stabilization of long-acting injectable (LAI) suspensions of a practically insoluble drug, …

Neither azacitidine injection nor triamcinolone acetonide injectable suspension is intended for long-term use in patients. Potential safety and efficacy risks associated with this LAI …

2008年5月22日 · Besides enhanced dissolution rates, and thereby, improved bioavailability, nanoparticles can also provide targeting capabilities when injected intravenously. The latter …